Bosentan D
Phase 3
- Conditions
- Digital ulcers associated with systemic sclerosis
- Registration Number
- JPRN-jRCT2080222130
- Lead Sponsor
- Actelion Pharmaceuticals Japan Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Male and female patients aged 18 years or older who currently have or had an SSc-related digital ulcer within the last 5 years
Exclusion Criteria
Digital ulcers associated with a condition other than SSc.
Definitely diagnosed with PAH before starting the study treatment.
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety and tolerability endpoints<br>ECG,Vaital Sign,Blood samples
- Secondary Outcome Measures
Name Time Method the change of digital ulcers